Ferriprox (deferiprone) has certain exclusivity rights that prevent a company from making a generic version. After the first of these exclusivity rights expires in October 2016, it may be possible for a generic Ferriprox product to be made. However, there may be lawsuits or patents for other uses that may change this date.
Can I Buy Generic Ferriprox?
Ferriprox® (deferiprone) is a prescription medication used to help the body remove excess iron. It is approved for use in people with excess iron due to blood transfusions used to treat thalassemia. It belongs to a group of drugs known as iron chelators.
Ferriprox is manufactured by Apotex, Inc., for ApoPharma USA, Inc. It is currently under the protection of exclusivity rights that prevent any generic versions of Ferriprox from being manufactured in the United States.
When Will a Generic Version Be Available?
The first of Ferriprox's exclusivity rights is set to expire in October 2016 (exclusivity rights are similar to patents but not quite the same). This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to delay or shorten this exclusivity period. This could include things such as lawsuits or other patents for Ferriprox uses.
Is Deferiprone a Generic Ferriprox?
No -- deferiprone is the active ingredient in Ferriprox, but is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Ferriprox [package insert]. Rockville, MD: ApoPharma USA, Inc.;2011 October.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 2, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click